| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/16/2013 | US8420885 Determining the capability of a test compound to affect solid tumor stem cells |
| 04/16/2013 | US8420794 Anti-influenza M2e antibody |
| 04/16/2013 | US8420784 Interleukin 10 receptor, (IL-10R) antibodies |
| 04/16/2013 | US8420607 Anthrax carbohydrates, synthesis and uses thereof |
| 04/16/2013 | US8420396 For delivering DNA/RNA into cells |
| 04/16/2013 | US8420353 Humanized antibody and process for preparing same |
| 04/16/2013 | US8420340 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 04/16/2013 | US8420311 Method to block the infection by flaviviruses, molecules and uses |
| 04/16/2013 | US8420107 Peptide vaccines against group A streptococci |
| 04/16/2013 | US8420106 Extramuscular treatment of traumatic-induced migraine headache |
| 04/16/2013 | US8420105 Botulinum toxin administration to treat various conditions |
| 04/16/2013 | US8420104 Lentiviral gene transfer vectors and their medicinal applications |
| 04/16/2013 | US8420103 Papillomavirus vaccines |
| 04/16/2013 | US8420102 Compositions that include hemagglutinin |
| 04/16/2013 | US8420101 Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic Escherichia coli |
| 04/16/2013 | US8420099 Chimeric protein for prevention and treatment of HIV infection |
| 04/16/2013 | US8420098 Fibronectin based scaffold domain proteins that bind to PCSK9 |
| 04/16/2013 | US8420097 DNA sequence, and recombinant preparation of the grass pollen allergen Lol p 4 |
| 04/16/2013 | US8420095 Antigen-containing microspheres for the treatment of allergies |
| 04/16/2013 | US8420093 Anti-ADDL monoclonal antibody and use thereof |
| 04/16/2013 | US8420091 Matriptase protein and uses thereof |
| 04/16/2013 | US8420090 Recombinant B. pseudomallei adhesin protein and methods and uses thereof |
| 04/16/2013 | US8420089 Antagonists of IL-6 to raise albumin and/or lower CRP |
| 04/16/2013 | US8420088 Methods and compositions using FGF23 fusion polypeptides |
| 04/16/2013 | US8420087 Interleukin-12 targeted to oncofoetal fibronectin |
| 04/16/2013 | US8420085 Anti-IGF-IR antibodies and uses thereof |
| 04/16/2013 | US8420084 Fully human antibodies specific to CADM1 |
| 04/16/2013 | US8420083 Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof |
| 04/16/2013 | US8420082 Neutralizing antibodies against GDF-8 and uses therefor |
| 04/16/2013 | US8420081 Antibody formulations and methods of making same |
| 04/16/2013 | US8420075 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 04/16/2013 | US8420072 Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus x O. aureus) with an inactivated Vibrio vulnificus vaccine |
| 04/16/2013 | CA2628315C Compositions and methods for the detection of trypanosoma cruzi infection |
| 04/16/2013 | CA2568162C Binding molecules capable of neutralizing rabies virus and uses thereof |
| 04/16/2013 | CA2555694C Anti-epcam immunoglobulins |
| 04/16/2013 | CA2534579C Live attenuated bacterial vaccine |
| 04/16/2013 | CA2527722C Biodegradable poly(beta-amino esters) and uses thereof |
| 04/16/2013 | CA2478169C Human antibodies specific to kdr and uses thereof |
| 04/16/2013 | CA2465973C Posh nucleic acids, polypeptides and related methods |
| 04/16/2013 | CA2412504C Antigenic polypeptides |
| 04/16/2013 | CA2379087C Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 04/16/2013 | CA2361246C Identification of specific differentially expressed antigens |
| 04/16/2013 | CA2271783C Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 04/14/2013 | CA2788253A1 Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab |
| 04/11/2013 | WO2013052772A2 Anti-human sema4a antibodies useful to treat disease |
| 04/11/2013 | WO2013052607A1 Human notch1 decoys |
| 04/11/2013 | WO2013052174A2 Methods for preventing and treating staphylococcus aureus colonization, infection, and disease |
| 04/11/2013 | WO2013052095A2 Vaccine |
| 04/11/2013 | WO2013051936A1 Adjuvant compound |
| 04/11/2013 | WO2013051891A1 Anti c-met antibody and uses thereof |
| 04/11/2013 | WO2013051878A2 Antibody specifically binding to epitope in sema domain of c-met |
| 04/11/2013 | WO2013051294A1 Antigen-binding molecule for promoting clearance from plasma of antigen comprising saccharide chain receptor-binding domain |
| 04/11/2013 | WO2013051001A1 Combination therapy with erbb ligands binding molecules |
| 04/11/2013 | WO2013050947A1 Composition comprising bacillus calmette guerin with cox2 selective/preferential inhibitor and uses thereof |
| 04/11/2013 | WO2013050725A1 Ige anti -hmw-maa antibody |
| 04/11/2013 | WO2013050567A1 Phosphospecific antibodies recognising tau |
| 04/11/2013 | WO2013050540A1 Wnt4 and med12 for use in the diagnosis and treatment of tumor diseases |
| 04/11/2013 | WO2013050445A1 Removal of tumor cells from intraoperative autologous blood salvage |
| 04/11/2013 | WO2013050048A2 Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped rna viruses |
| 04/11/2013 | WO2013050034A1 Production of a cysteine rich protein |
| 04/11/2013 | WO2013049941A1 Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof |
| 04/11/2013 | WO2013049931A1 Recombinant b. pseudomallei adhesin protein and methods and uses thereof |
| 04/11/2013 | WO2013024157A3 Combinations of anti -hcv - entry factor antibodies, protein kinase inhibitors or alisporivir for the treatment and the prevention of hcv infection |
| 04/11/2013 | WO2013024156A3 Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection |
| 04/11/2013 | WO2013009521A3 Methods and compositions for treating asthma using anti-il-13 antibodies |
| 04/11/2013 | WO2013006569A3 Herpes virus vaccine and methods of use |
| 04/11/2013 | WO2013003801A3 Inhibitor of neuronal connectivity linked to schizophrenia susceptibility and cognitive dysfunction |
| 04/11/2013 | WO2012170911A3 Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy |
| 04/11/2013 | WO2012170776A3 Methods of determining a patient's prognosis for recurrence of prostate cancer and/or determining a course of treatment for prostate cancer following a radical prostatectomy |
| 04/11/2013 | WO2012156564A3 Polymer microspheres as adjuvants in the production of vaccines against scuticociliate fish parasites |
| 04/11/2013 | WO2012153193A3 Protein-active agent conjugates and method for preparing the same |
| 04/11/2013 | WO2012125551A8 Listeria-based adjuvants |
| 04/11/2013 | WO2012047941A3 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 04/11/2013 | WO2012012759A3 Anti-tumor antigen antibodies and methods of use |
| 04/11/2013 | WO2012006367A3 Compositions and methods for treating influenza |
| 04/11/2013 | WO2011153431A3 Peripheral blood sparc antibodies and uses thereof |
| 04/11/2013 | WO2011153416A3 Novel anti-s1p antibody variants of lt1009 |
| 04/11/2013 | US20130091591 Artery- and vein-specific proteins and uses therefor |
| 04/11/2013 | US20130089927 Hematopoietic Cell E-Selectin/L-Selectin Ligand Polypeptides and Methods of Use Thereof |
| 04/11/2013 | US20130089913 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 04/11/2013 | US20130089596 Compositions and methods of making and using influenza proteins |
| 04/11/2013 | US20130089573 Novel process |
| 04/11/2013 | US20130089572 Partially Hydrolyzed Casein-Whey Nutritional Compositions For Reducing The Onset Of Allergies |
| 04/11/2013 | US20130089571 Vaccine |
| 04/11/2013 | US20130089570 Oral vaccine compromising an antigen and a toll-like receptor agonist |
| 04/11/2013 | US20130089569 Recombinant mva capable of expressing structural hcv antigens |
| 04/11/2013 | US20130089566 Vaccine preventing and/or treating autoimmune diseases |
| 04/11/2013 | US20130089564 Therapeutic Uses of Glandular Kallikrein |
| 04/11/2013 | US20130089562 Methods of treating liver conditions using notch2 antagonists |
| 04/11/2013 | US20130089561 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 04/11/2013 | US20130089560 Bone morphogenetic protein receptor binding agents and methods of their use |
| 04/11/2013 | US20130089558 Dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 04/11/2013 | US20130089557 Antibody specifically binding to epitope in sema domain of c-met |
| 04/11/2013 | US20130089556 Anti c-met humanized antibody and uses thereof |
| 04/11/2013 | US20130089555 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE |
| 04/11/2013 | US20130089553 Method for making heteromultimeric polypeptides |
| 04/11/2013 | US20130089551 Treatment of pulmonary edema |
| 04/11/2013 | US20130089544 Antibodies Directed to ERBB2 |
| 04/11/2013 | US20130089542 Anti c-met antibody and uses thereof |
| 04/11/2013 | US20130089539 Kim-1 antibodies for treatment of th2-mediated conditions |